Financial Statements · Financial Reporting

Aktsiaselts CHEMI-PHARM

Official identifier 10140819Record date 31 Dec 2020
Estonia

Report

Legal form
AS
Report status
Registered

Dates

Reporting year
2020
Period start
1 Jan 2020
Submitted date
3 Jun 2021

Report

Consolidated
No
Audited
Yes

Financial metrics

StatementMetricValue
Balance sheetAssets9,313,220
Balance sheetCash and cash equivalents2,413,326
Balance sheetCurrent assets7,203,245
Balance sheetCurrent liabilities1,157,472
Balance sheetEquity8,034,663
Balance sheetShare capital at nominal value25,600
Balance sheetNon-current assets2,109,975
Balance sheetNon-current liabilities121,085
Balance sheetRetained earnings (loss) from previous periods3,423,862
Income statement scheme 1Depreciation and impairment of non-current assets-140,810
Income statement scheme 1Labour costs-2,424,699
Income statement scheme 1Revenue18,479,363
Income statement scheme 1Annual period profit / loss4,582,645
Income statement scheme 1Operating profit (loss)4,497,026
Income statement scheme 1Profit (loss) before income tax4,601,520
Profit distribution proposalRetained earnings (loss) from previous periods3,423,862
Kasumi jaotamise otsusRetained earnings (loss) from previous periods3,423,862
Note: Labour costsEmployees62
Note: Labour costsLabour costs2,424,699
Rahavoogude aruanne kaudsel meetodilDepreciation and impairment of non-current assets140,810
Rahavoogude aruanne kaudsel meetodilOperating profit (loss)4,497,026

Linked company

Company: Aktsiaselts CHEMI-PHARM

Source

Estonian e-Business Register Annual Reports open data

View published source

Back to Financial Statements